Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

NASOSTAT

K-Number: K781615 · 1978-10-11

Decision Date1978-10-11
Product CodeEMX
Advisory CommitteeEN
DecisionSubstantially Equivalent

Device Summary

NASOSTAT is the device name listed in this FDA 510(k) record. The listed applicant is Nasostat, Inc.. It received FDA 510(k) clearance on 1978-10-11 under 510(k) number K781615. The device is classified under product code EMX. It was reviewed by the EN advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the NASOSTAT?

NASOSTAT is a medical device that received FDA 510(k) clearance on 1978-10-11. The listed applicant is Nasostat, Inc.. The 510(k) number is K781615.

When did NASOSTAT receive FDA 510(k) clearance?

NASOSTAT received FDA 510(k) clearance on 1978-10-11, under 510(k) number K781615.

Who is the listed applicant for NASOSTAT?

The FDA 510(k) record lists Nasostat, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for NASOSTAT?

The FDA product code for NASOSTAT is EMX.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: EMX)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑